plasmid pet14b (Sangon Biotech)
90
Structured Review
Sangon Biotech
plasmid pet14b
Plasmid Pet14b, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+pet14b/pet+22b/pm38899839-274-14-16
Average 90 stars, based on 1 article reviews
Plasmid Pet14b, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasmid+pet14b/pet+22b/pm38899839-274-14-16
Average 90 stars, based on 1 article reviews
plasmid pet14b - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Synthesized:Article Title: Discovery of Antimicrobial Lysins from the “Dark Matter” of Uncharacterized Phages Using Artificial Intelligence Article Snippet: .. Genes of putative lysins were commercially synthesized into Article Title: Discovery of Antimicrobial Lysins from the "Dark Matter" of Uncharacterized Phages Using Artificial Intelligence. Article Snippet: The rapid rise of antibiotic resistance and slow discovery of new antibiotics have threatened global health.. While novel phage lysins have emerged as potential antibacterial agents, experimental screening methods for novel lysins pose significant challenges due to the enormous workload.. Here, the first unified software package, namely DeepLysin, is developed to employ artificial intelligence for mining the vast genome reservoirs (“dark matter”) for novel antibacterial phage lysins. Plasmid Preparation:Article Title: Discovery of Antimicrobial Lysins from the “Dark Matter” of Uncharacterized Phages Using Artificial Intelligence Article Snippet: .. Genes of putative lysins were commercially synthesized into Article Title: Discovery of Antimicrobial Lysins from the "Dark Matter" of Uncharacterized Phages Using Artificial Intelligence. Article Snippet: The rapid rise of antibiotic resistance and slow discovery of new antibiotics have threatened global health.. While novel phage lysins have emerged as potential antibacterial agents, experimental screening methods for novel lysins pose significant challenges due to the enormous workload.. Here, the first unified software package, namely DeepLysin, is developed to employ artificial intelligence for mining the vast genome reservoirs (“dark matter”) for novel antibacterial phage lysins. Cloning:Article Title: Discovery of Antimicrobial Lysins from the "Dark Matter" of Uncharacterized Phages Using Artificial Intelligence. Article Snippet: The rapid rise of antibiotic resistance and slow discovery of new antibiotics have threatened global health.. While novel phage lysins have emerged as potential antibacterial agents, experimental screening methods for novel lysins pose significant challenges due to the enormous workload.. Here, the first unified software package, namely DeepLysin, is developed to employ artificial intelligence for mining the vast genome reservoirs (“dark matter”) for novel antibacterial phage lysins. Expressing:Article Title: Discovery of Antimicrobial Lysins from the "Dark Matter" of Uncharacterized Phages Using Artificial Intelligence. Article Snippet: The rapid rise of antibiotic resistance and slow discovery of new antibiotics have threatened global health.. While novel phage lysins have emerged as potential antibacterial agents, experimental screening methods for novel lysins pose significant challenges due to the enormous workload.. Here, the first unified software package, namely DeepLysin, is developed to employ artificial intelligence for mining the vast genome reservoirs (“dark matter”) for novel antibacterial phage lysins. Purification:Article Title: Discovery of Antimicrobial Lysins from the "Dark Matter" of Uncharacterized Phages Using Artificial Intelligence. Article Snippet: The rapid rise of antibiotic resistance and slow discovery of new antibiotics have threatened global health.. While novel phage lysins have emerged as potential antibacterial agents, experimental screening methods for novel lysins pose significant challenges due to the enormous workload.. Here, the first unified software package, namely DeepLysin, is developed to employ artificial intelligence for mining the vast genome reservoirs (“dark matter”) for novel antibacterial phage lysins. |
